AM PS
Natural health product licensed in Canada
- Licence holder
- Botanica Research
- NPN or DIN-HM
- 80092122
- Status
- Active licence
- Licence date
- 8 May 2019
- Revision date
- Not provided
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Malpighia glabra Source : Malpighia glabra, Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 mg | 60 mg | Not calculated |
| Astragalus membranaceus Source : Astragalus membranaceus - racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 mg | 50 mg | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Rhizome Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 150 mg | 25 mg | Not calculated |
| Glycyrrhiza glabra Source : Glycyrrhiza glabra - racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Hebanthe eriantha Source : Hebanthe eriantha - Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Ocimum tenuiflorum Source : Ocimum tenuiflorum - feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 mg | 25 mg | Not calculated |
| Piper nigrum Source : Piper nigrum - fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 100 mg | 5 mg | Not calculated |
| Panax ginseng Source : Panax ginseng - Leaf and Stem Extract : Matériel brut sec Extraction ratio : 14.28:1 Dry plant equivalent : 714 mg | 50 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 30 mg | Not calculated |
| Vitamine B6 Source : Pyridoxine | 5 mg | Not calculated |
| Withania somnifera Source : Withania somnifera - racine | 200 mg | Not calculated |
| L-Tyrosine Source : L-Tyrosine | 100 mg | Not calculated |
| Eleutherococcus senticosus Source : Eleutherococcus senticosus - racine Extract : Matériel brut sec Extraction ratio : 10:10,500 Dry plant equivalent : 6,250 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Poudre d'enveloppes d'Oryza sativa (Riz), Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
An antioxidant for the maintenance of good health. Helps in connective tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80092122
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.